The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nexium I.V. 40 mg Powder for solution for injection/infusion

Grunenthal Pharma LtdPA2242/013/004

Main Information

Trade NameNexium I.V. 40 mg Powder for solution for injection/infusion
Active SubstancesEsomeprazole
Dosage FormPowder for solution for injection/infusion
Licence HolderGrunenthal Pharma Ltd
Licence NumberPA2242/013/004

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC05 esomeprazole


License statusAuthorised
Licence Issued10/02/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back